1. General format: The manuscript files should be prepared as the following details.

  • Document type: word document
  • Font: 12-point Times New Roman
  • Layout: single column, 1.5-line spacing, continuous line numbering
  • Margins: 2.5 cm
  • Page numbering: bottom of each page

2. Language requirements

  • Language: English with proofread by an English professional or professional language editing service (please attach the English proofreading certificate with the submission)
  • Style: Either American or British English (not a mix)

3. Cover letter

  • Briefly state the manuscript’s importance and relevance to the journal’s readership.
  • Confirm the manuscript is not previously published or under consideration for publication elsewhere.
  • Include a conflict-of-interest statement.

4. Manuscript files: Prepare two separate files to ensure a double-blind peer review process:

  • Unblinded File: A manuscript including the title page with author information and affiliations consistent with the data in ORCID, as well as the corresponding author's contact details. This file also include the main content (please refer to article structure), conflict of interest statement, data availability, acknowledgements, funding support, and author contributions according to CRediT (Contributor Roles Taxonomy).
  • Blinded File: A manuscript excluding any author-identifying information.

5. Article structure: please see Manuscript Template

  • Abstract: Concise descriptive and self-explanatory abstract with succinct details of introduction and objectives, methods, results, conclusion, and up to five keywords. References, non-standard, or uncommon abbreviations should be avoided, but if essential, they must be defined at the first use in the abstract itself.
  • Introduction: Provide adequate background and objectives of the study, avoiding a detailed literature survey or a summary of the results.
  • Materials and methods: Sufficient details for reproducibility with references supporting the research protocols used in the study.
  • Results: Clearly explain the findings in a concise manner with linked to, but not redundant with, related tables/figures. 
  • Discussion: Briefly explain the key findings, and discuss the findings points-by-points with supporting or contradicting references. 
  • Conclusion: Summarize main findings with clinical contribution.
  • Take home messages: No more than 50 words, or Clinical implication: 3-4 concise bullet points.
  • References

6. Clinical Trials

All clinical trials starting after June 1, 2025, are encouraged to be prospectively registered in a public registry (international or Thai registry) prior to the trial's commencement. The journal recommends including the trial registry number in the manuscript and providing it at the time of submission.

 

7. Reporting Guidelines

Submitted manuscripts are encouraged to adhere to the reporting guidelines outlined by the Equator Network (http://www.equator-network.org/). When applicable, authors should submit the relevant checklists alongside their manuscript to specify where each reporting item is addressed. The relevant guidelines include:

  • CONSORT for randomized trials
  • STROBE for observational studies
  • PRISMA for systematic reviews
  • STARD for diagnostic/prognostic studies
  • ARRIVE for pre-clinical animal studies
  • SCRIBE for single-case behavioral interventions

8.Limits: There are specific limits on word count, tables, figures, and references based on article type as presented below